MIRA Pharmaceuticals, Inc. (MIRA)

NCM – Real vaqt narxi. Valyuta: USD

0.74

-0.03 (-4.23%)

Bozor ochiq: Aug 12, 2026, 1:51 PM EDT

0.79

+0.01 (1.54%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

06.08.2026

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Obesity Treatment Candidate Designed to Preserve Lean Body Mass Toxicokinetic Findings De-Risk Dose Selection and Support Regulatory Pathway Toward IND MIAMI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral small-molecule therapeutics, today announced positive toxicokinetic findings from a 7-day repeated-dose study of SKNY-1 in Beagle dogs. The study demonstrates dose-dependent systemic exposure and rapid absorption that de-risk dose selection and support advancement toward GLP toxicology studies and IND-enabling development.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

MIRA Pharmaceuticals, Inc. (MIRA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

MIRA Pharmaceuticals, Inc. (MIRA)

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Videolar

No Data

Press-relizlar

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Videolar

No Data

Press-relizlar

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Search stocks

MIRA Pharmaceuticals, Inc. (MIRA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

MIRA Pharmaceuticals, Inc. (MIRA)

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Videolar

No Data

Press-relizlar

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Videolar

No Data

Press-relizlar

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1